trial · primary record
Visbiome
Type 1 Diabetes
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 43 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Effect of Multistrain Probiotic on Immune System Inflammation as measured by plasma transcription analysis |
| Registry ID | NCT04141761 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:26.325Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04141761
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.